TPM3–NTRK1 fusion confers resistance to osimertinib in lung adenocarcinoma: a model in a continuous cell line

作者：Fang Cao, Jiayin Dai, Kun Dong, Zhenli Yang, Yanli Zhu, Changsong Qi, Dongmei Lin, Xiaocui Bian, Yuqin Liu · 发表于：Human Cell · 年份：2025 · DOI：10.1007/s13577-025-01315-7 · 被引用次数：3 · 研究领域：Lung Cancer Treatments and Mutations、PI3K/AKT/mTOR signaling in cancer、Cancer-related Molecular Pathways